Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis

Publikation: Bidrag til tidsskriftLederForskning

OriginalsprogEngelsk
TidsskriftCancer
Vol/bind123
Udgave nummer14
Sider (fra-til)2600-2603
ISSN0008-543X
DOI
StatusUdgivet - 2017

ID: 195590129